MARKET PULSE-Primero, First Solar, Zynga, Cache, Avon, Leap

Oct 5 (Reuters) - Some U.S. stocks on the move on Friday:

(For the Morning News Call newsletter click on ;

For The Day Ahead newsletter click on )


The Dow Jones industrial average climbed to its highestlevel in nearly five years after an unexpected drop in theunemployment rate pointed to an improving economy.

The Dow Jones industrial average rose 55.87 points,or 0.41 percent, to 13,631.23. The Standard & Poor's 500 Index

was up 4.52 points, or 0.31 percent, to 1,465.92. TheNasdaq Composite Index increased 1.18 points, or 0.04percent, to 3,150.64.

** PRIMERO MINING CORP , $7.16, up 32.6 pct(1256 ET)

The junior gold miner said it received a positive rulingfrom Mexican tax authorities on how it reports silver revenues.

** FLEETMATICS GROUP PLC , $22.98, up 35.2 pct (1256ET)

The company's niche software business stood out in anotherwise lackluster IPO market.

The Irish fleet management software provider had priced itsinitial public offering of 7.8 million shares at the high end ofits expected price range of $15 to $17 apiece, raising about$133 million.

** ZYNGA INC , $2.31, down 17.2 pct (1256 ET) ** FACEBOOK INC , $21.47, down 2.2 pct (1256 ET) ** GLU MOBILE INC , $4.01, down 6.2 pct (1257 ET)

Brokerages lowered their price targets on the stock by up to40 percent after the "Farmville" game maker slashed its 2012outlook for the second time due to a decline in the number ofpaying customers.

Facebook, which derives over a tenth of its revenue fromfees paid by Zynga, was also down as was Glu Mobile.

** CACHE INC , $2.69, down 17.2 pct (1259 ET)

The women's apparel retailer forecast a wider loss in thethird quarter, compared to its earlier expectations, as thecompany increased promotions to clear out excess summerinventory, and its fall styles also failed to work withshoppers.

** DATALINK CORP , $7.46, down 13 pct (1259 ET)

The company, which makes data storage systems and software,estimated third-quarter results below its forecast as customersheld back on spending.

Several brokerages including Canaccord Genuity, Needham & Coand Cantor Fitzgerald cut their price targets on the company'sstock.

** MERCURY COMPUTER SYSTEMS INC , $7.87, down18.3pct (1300 ET)

Lazard Capital Markets downgraded the signal and imageprocessing systems maker to "neutral." Jefferies & Co cut itsprice target on the stock to $7.70 from $12.

** INTELIQUENT , $7.80, down 14 pct (1300 ET)

The ethernet network provider said negotiations with a largecustomer may reduce rates significantly. Robert W. Baird & Codowngraded the stock to "neutral," saying the company'sannounced dividend of $3 was below expectations.

** SUNESIS PHARMACEUTICALS INC , $6.59, up 12.8 pct(1301 ET)

Roth Capital raised its price target on the stock, saying ananalysis of interim data of the company's blood cancer drugVosaroxin fell into a "promising" zone. The company released thedata of its late-stage VALOR trial at an analysts' conference onThursday. The brokerage raised the price target to $12 from $7.

** XENOPORT INC , $12.33, up 10.7 pct (1327 ET)

The pharmaceutical company reported favorable preliminaryresults from an early-stage trial for its drug XP23829, intendedto treat multiple sclerosis and psoriasis.

** FIRST SOLAR INC , $20.25, down 10.3 pct (1302 ET)

The largest U.S. solar panel's spokesman confirmed therewere reliability issues with more than 200,000 of its panels.Brokerage Avian Securities LLC downgraded the stock.

** WISDOMTREE INVESTMENTS INC , $6.89, up 8.6 pct(1302 ET)

Goldman Sachs added the company to its "conviction buy" listsaying investment management company was insulated from pricecompetition in the exchange-traded funds space, and was poisedto gain market share in an attractive niche.

** TRIQUINT SEMICONDUCTOR INC , $5.35, up 6.8 pct(1302 ET)

Lazard Capital Markets started coverage on the chipmaker'sstock with a "buy" rating.

** F5 NETWORKS INC , $104.93, down 2.3pct (1305 ET)

Barclays Capital downgraded the network gear maker's stockto "equal weight" from "overweight" and cut its price target onthe stock to $105 from $115.

** PEP BOYS-MANNY MOE AND JACK , $10.38, up 5.4 pct(1305 ET)

Benchmark Co upgraded the auto repair chain to "buy" from"hold," saying an improving tire profit environment and apossible debt refinance will likely lead to earnings growth. Thebrokerage also raised its rating on Pep Boys's stock to $12 from$10.

** CONSTELLATION BRANDS INC , $36.14, up 4 pct (1305ET)

The world's largest branded-wine company's quarterlyearnings beat Wall Street estimates, and the world's largestbranded wine company forecast strong results for the fiscalyear, helped by new brands and increased promotionalspending.

** ARBOR REALTY TRUST INC , $5.66, down 6.4 pct (1306ET)

The real estate finance company announced a public offeringof 3.5 million common shares.

** AVON PRODUCTS INC , $17.19, up 6 pct (1306 ET)

The cosmetics company said Executive Chairman Andrea Jung,who was replaced as chief executive in April, has decided tostep down from the board at the end of 2012, ending what becamea tumultuous tenure in recent years.

** ORACLE CORP , $31.51, down 1.2 pct (1307 ET)

The company has all the pieces it needs to compete in cloudcomputing but is always interested in looking at compelling M&Aopportunities, Chief Financial Officer Safra Catz toldinvestors.

** INFORMATICA CORP , $27.45, up 5.5 pct (1307 ET)

Nomura Equity Research upgraded the software maker to "buy"from "neutral," saying while it may take time for the company toturn its sales force issues around, the stock is trading at anattractive level after Thursday's 23 percent drop.

** SPRINT NEXTEL CORP , $5.20, up 2.2 pct (1307 ET)

** METROPCS COMMUNICATIONS INC , $12.75, up 0.5 pct(1308 ET)

** LEAP WIRELESS INTERNATIONAL INC , $6.23, up 6.5pct (1308 ET)

Sprint Nextel is considering making a rival bid forMetroPCS, which agreed on Wednesday to a merger with DeutscheTelekom AG's T-Mobile USA, according to peoplefamiliar with the situation.

The stock of Leap Wireless was also up on the news. ** THE MEDICINES CO , $25.37, down 4.8 pct (1308 ET)

The company said it discontinued a mid-stage study of itsexperimental drug to reduce blood loss during surgery due toevidence of risk to patients.

(Complied by Aditi Shrivastava in Bangalore)

(aditi.shrivastava@thomsonreuters.com, within U.S. +1 646 2238780, outside U.S. +91 80 4135 5783, Reuters messaging:aditi.shrivastava.reuters.com@reuters.net)